What is a hemorrhagic ovarian cyst?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A hemorrhagic ovarian cyst is a fluid-filled sac on the ovary that has experienced bleeding inside it, typically forming during ovulation and often resolving on its own within 4-8 weeks without specific treatment. These cysts are generally benign and can be characterized by a reticular pattern or a retracting clot on ultrasound imaging 1. According to the O-RADS US risk stratification and management system, typical hemorrhagic cysts in the premenopausal age group that are less than or equal to 5 cm require no further management, while those greater than 5 cm but less than 10 cm should be followed up in 8-12 weeks 1.

Key Characteristics and Management

  • Hemorrhagic cysts typically form during ovulation when the follicle that releases an egg doesn't dissolve properly and instead fills with blood.
  • Symptoms may include pelvic pain, irregular menstrual bleeding, pain during intercourse, or no symptoms at all.
  • Treatment usually involves pain management with over-the-counter medications like ibuprofen or acetaminophen.
  • For severe pain, a healthcare provider might prescribe stronger pain relievers, and applying a heating pad to the lower abdomen can also help relieve discomfort.
  • Medical attention should be sought if pain becomes severe, is accompanied by fever, or if there's sudden, sharp pain that might indicate a ruptured cyst.

Diagnostic Considerations

  • Ultrasound imaging is crucial in diagnosing and characterizing hemorrhagic cysts, with features such as a reticular pattern or a retracting clot 1.
  • The O-RADS US risk stratification and management system provides guidelines for the management of hemorrhagic cysts based on their size and the patient's menopausal status 1.
  • Recent studies have demonstrated that the risk of malignancy in benign-appearing adnexal lesions, including hemorrhagic cysts, is less than 1% 1.

Clinical Implications

  • Given the low risk of malignancy and the high likelihood of spontaneous resolution, conservative management with serial ultrasound follow-up is often the recommended approach for hemorrhagic cysts 1.
  • However, it is essential to follow the guidelines set by the O-RADS US risk stratification and management system to ensure appropriate management and to minimize the risk of missing a potentially malignant lesion 1.

From the Research

Definition and Characteristics

  • A hemorrhagic ovarian cyst is a functional cyst resulting from bleeding into a follicular or corpus luteum cyst 2.
  • It is a common gynaecological condition that often presents with acute pelvic pain, typically localized to one side, and may be accompanied by menstrual irregularities 2.
  • Hemorrhagic ovarian cysts (HOCs) are frequently seen in reproductive age women, developing in the luteal phase of ovulatory cycles 3.

Diagnosis and Presentation

  • Diagnosis is usually made via pelvic ultrasound, which typically reveals a complex cyst with characteristic features such as a reticular or 'lace-like' pattern 2.
  • Clinical symptoms are mainly due to peritoneal irritation by the blood effusion 4.
  • The differential diagnosis is extensive and standard management is not defined 4.
  • Ultrasound is the first-line investigation and is diagnostic in the case of haemorrhage 5.

Complications and Management

  • Complications such as rupture or significant hemorrhage may necessitate surgical intervention 2.
  • Rupture of a hemorrhagic ovarian cyst can lead to hemoperitoneum, which can create a risk of further adverse events including hypovolemic shock 6.
  • Surgical therapy should be laparoscopic, with surgical options such as luteumectomy, ovarian wedge-shaped excision or oophorectomy 4.
  • Prevention of further episodes can be achieved by suppressing ovulation, usually with the combined oral contraceptive, or by fixation of the ovary to prevent recurrent torsion 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Atypical Presentation of a Giant Hemorrhagic Ovarian Cyst.

Journal of obstetrics and gynaecology of India, 2022

Research

Hemorrhagic corpus luteum: Clinical management update.

Turkish journal of obstetrics and gynecology, 2020

Research

Diagnosis and management of ovarian cyst accidents.

Best practice & research. Clinical obstetrics & gynaecology, 2009

Related Questions

What are the symptoms and treatment options for a hemorrhagic ovarian cyst?
What is the recommended management for a premenopausal woman with a 5.6cm left hemorrhagic ovarian cyst, associated pain, separation, free floating fluid in the cul-de-sac, and left adnexal involvement?
What is the appropriate management for a 2.4 cm ovarian hemorrhagic cyst?
What is the diagnosis and management for a 12-year-old female patient with abdominal pain, vomiting, and a history of only one menstrual cycle, who presents with a bulky right ovary replaced by a thick-walled cystic lesion with low-level internal echoes and internal septations on ultrasound (USG), along with mild free fluid in the pouch of Douglas (POD) and multiple prominent subcentimetric mesenteric lymph nodes?
What are the next steps for a female of reproductive age with a ruptured ovarian cyst, presenting with brown vaginal discharge with clots?
What is the diagnosis and treatment for Mycosis fungoides (Cutaneous T-cell lymphoma)?
What part of the cell is affected by deficient glycosylation (glycosylation refers to the process of attaching carbohydrate molecules to target proteins or lipards)?
What is the role of BPC-157 (Body Protection Compound 157) in medical treatment?
What are the clinical presentation, blood tests, and diagnostic criteria for Mycosis Fungoides (Cutaneous T-cell Lymphoma)?
Are hospice patients prescribed statins (HMG-CoA reductase inhibitors) for hyperlipidemia?
Can nocturnal oxygen therapy reduce nasal and sinus mucous production?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.